Franchini E, Porlezza M
Blood Bank, G. Gaslini Research Children's Hospital, Genoa, Italy.
Haematologica. 1991 Mar;76 Suppl 1:15-7.
The availability of reliable and standardizable procedures with low contamination risk and less prominent loss in MNC, would solve the existing perplexities about the systematic use of this passage. We tried to experiment Areman's et al protocol that utilizes the CS 3000 blood cell processor without gradient, making some changes and comparing the results with those achieved with the COBE 2991 on Ficoll. Some aspects should be defined, but the preliminary results are undoubtedly of great interest.
具备低污染风险且单核细胞损失不显著的可靠且标准化程序，将解决关于该通道系统使用的现有困惑。我们尝试对阿雷曼等人的方案进行实验，该方案在不使用梯度的情况下利用CS 3000血细胞处理器，做出一些改变，并将结果与在菲可分离液上使用COBE 2991所取得的结果进行比较。一些方面有待明确，但初步结果无疑非常有趣。
